Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

NCT01522248 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Influenza Virus Vaccine

Interventions

BIOLOGICAL: Trivalent Inactivated Influenza vaccine

Sponsor

Johns Hopkins Bloomberg School of Public Health